Current status of immunotherapy for the treatment of lung cancer.

  title={Current status of immunotherapy for the treatment of lung cancer.},
  author={Sanjay Murala and Vamsi A Alli and Daniel Kreisel and Andrew E. Gelman and Alexander S Krupnick},
  journal={Journal of thoracic disease},
  volume={2 4},
Immunotherapy is a novel approach for the treatment of systemic malignancies. Passive and adaptive immunotherapy have been applied to the treatment of a wide variety of solid tumors such as malignant melanoma (1), renal cell carcinoma (2) and ovarian cancer (3). Several early clinical trials of immune based therapy for both non-small (NSCLC) and small cell lung cancer (SCLC) have demonstrated limited or no success (3),(4) but recent trials of antigen-specific cancer immunotherapy have shown… CONTINUE READING
14 Citations
85 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 14 extracted citations


Publications referenced by this paper.
Showing 1-10 of 85 references

, 1975 - 2006 , featuring colorectal cancer trends and impact of interventions ( risk factors , screening , and treatment ) to reduce future rates

  • WB Coley
  • 2010

effect of minor histocompatibility antigen HA - 1 in chronic myeloid leukemia patients

  • JP Lacour, C Caldani, A Thyss, M Schneider, JP Ortonne
  • 2010

Similar Papers

Loading similar papers…